Goodfella's pizza recalled after health risk packing mistake
Birds Eye Ltd. is recalling Goodfella's Stonebaked Thin Garlic Bread because it contains milk which is not mentioned on the label. The garlic bread has been mispacked with a garlic bread that contains cheese. This means the product is a possible health risk for anyone with an allergy or intolerance to milk or milk constituents.
Birds Eye is recalling the product from customers and has contacted the relevant allergy support organisations, which will tell their members about the recall. The company has also issued a point-of-sale notice to its customers. These notices explain to customers why the product is being recalled and tell them what to do if they have bought the product.
Data suggests that about 8% of the UK population is affected by lactose intolerance. Lactose intolerance is more prevalent among people of Asian or African-Caribbean descent in the UK.
READ MORE: Aldi customer says she found 'bumhole in stewed steak tin'
READ MORE: Pensioner seen wheeling 'decomposed' body of daughter around UK shopping centre
Globally, approximately 65% of people experience some form of lactose intolerance, with higher rates observed in East Asian populations
Goodfella's Stonebaked Thin Garlic Bread
Pack size
5020
December 2025
If you have bought the product and have an allergy or intolerance to milk, do not eat it. Instead return it to the store from where it was bought for a full refund. For more information, go to the Goodfella's contact us page at https://contactus.goodfellaspizzas.com/s/ or call the Birds Eye UK Freephone number on 0800 088 5573.
Sometimes there will be a problem with a food product that means it should not be sold. Then it might be 'withdrawn' (taken off the shelves) or 'recalled' (when customers are asked to return the product). Sometimes foods have to be withdrawn or recalled if there is a risk to consumers because the allergy labelling is missing or incorrect or if there is any other food allergy risk. When there is a food allergy risk, the FSA will issue an Allergy Alert.
A milk allergy is an immune system reaction to proteins in milk (usually casein or whey). Symptoms can appear within minutes to hours after consuming dairy.
Skin reactions – Hives, rash, redness, or eczema
Swelling – Lips, face, tongue, or throat (angioedema)
Digestive issues – Vomiting, diarrhoea, stomach cramps
Respiratory symptoms – Wheezing, coughing, shortness of breath, nasal congestion
Anaphylaxis (Severe reaction) – Can cause difficulty breathing, drop in blood pressure, and loss of consciousness (requires emergency treatment)
Colic-like symptoms (in infants)
Persistent vomiting or diarrhoea
Blood or mucus in stool (common in babies with milk allergy)
Eczema flare-ups
Unlike lactose intolerance (which affects digestion due to lack of lactase enzyme), a milk allergy is an immune reaction and can be life-threatening. If you suspect a milk allergy, it's best to see a doctor for allergy testing.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Stinging, invasive Asian needle ants found in Ohio. Here's where, why they're a problem
A species of invasive stinging ants is on the rise as they hit peak season in the summer. Asian needle ants deliver a painful and venomous sting capable of causing allergic or even life-threatening reactions. Native to Asia, the insects are known as Brachyponera chinensis (roughly translated as "short, wicked ant from China") and have since spread to the U.S. with documented sightings in 20 states, including Ohio. While tiny, the ants can also infest homes and disrupt natural environments by excluding native ant species and termites. Asian needle ants reach their yearly peak activity in June and July. Here's what to know before they arrive. Asian needle ants are a species of carnivorous ants native to China, Japan and the Koreas, according to USA TODAY. These dark brown ants have been found to live in colonies in leaf litter and rotted logs but can also be found inside potted plants, underneath wood piles, and in lawns. The "needle" part of its name refers to its stinger. While they are difficult to track, Asian needle ants have been found in Ohio with at least four reported sightings, per More than a dozen other states have reported Asian needle ant sightings. Ohio State University's Buckeye Yard and Garden confirmed the non-native stinging ant species in Southwest Ohio. The ants can nest inside landscape mulch, compost bins, homes, kitchens and dumpsters. No. Unlike fire ants, Asian needle ants are smaller, less aggressive and will try to avoid humans, however, most stings occur when someone accidentally places their hands in nests or on the ants, according to NC State University Entomology. The pressure causes them to deliver a defensive sting that can last for hours or even days. Experts recommend wearing thick gloves when handling outdoor items like mulch to help prevent stings. Eliminating nesting sites is also advised, including reducing moisture-heavy areas in and around your home and sealing entry points, according to Orkin. Should you encounter a colony of Asian needle ants, protein-based insecticide baits can also be used, though the method isn't foolproof. According to the U.S. Department of Agriculture, Asian needle ant stings can include the following symptoms: Skin reactions include hives, itching, and flushed or pale skin. Low blood pressure (hypotension). Constriction of the airway, wheezing, and difficulty breathing. Swollen tongue or throat. Weak and rapid pulse. Nausea, vomiting, or diarrhea. Dizziness or fainting. Psychological symptoms, such as a feeling of impending doom. This article originally appeared on Cincinnati Enquirer: Stinging Asian needle ants spotted in Ohio. Here's why it's a problem
Yahoo
3 hours ago
- Yahoo
What to know about invasive ant with fatal sting reported in multiple states
The Joro spider, Asian long-horned beetle and spotted lanternfly have company this summer. A "sneaky" invasive species that has a potentially deadly sting continues to spread across the U.S. and can be found in more than a dozen states, according to experts. Asian needle ants were first detected in the U.S. almost a century ago, but the species has continued to expand its reach, primarily throughout the Southeast, and this pest could potentially be deadly to humans, according to Dan Suiter, a professor of urban entomology at the University of Georgia. "It injects venom that can harm you. Its sting can be life threatening," Suiter recently told the university. Suiter added that people who have adverse reactions to bee and ant stings are especially vulnerable and could go into anaphylactic shock from the needle ant's sting. Anaphylaxis is a potentially life-threatening allergic reaction that can occur within seconds of being exposed to something you're allergic to, such as a sting, according to the Mayo Clinic. "If you suffer from anaphylaxis, you should really know what this ant looks like," Suiter says. "And it might be smart to carry an EpiPen." Suiter urged people to be vigilant for these invasive species, especially with ant populations peaking later this summer. What are Asian needle ants? Asian needle ants are technically known as Brachyponera chinensis – roughly translated as "short, wicked ant from China" – but their native range also includes Japan and the Koreas, according to the U.S. Forest Service. The insect was first discovered in the U.S. in 1932 in Georgia, but has only recently started to "cause problems in North America after being relatively unnoticed for many years," the U.S. Forest Service says. The pest has now been detected all the way from Washington state to Florida, according to the site as well as Mississippi State University, and the ant is recently getting more attention in Texas. Suiter says Asian needle ants are "sneaky" because they are less than a quarter of an inch long and are adept at hiding. "Unlike many invasive species that tend to colonize areas in the wake of natural or human disturbance, Asian needle ants are capable of invading undisturbed forest areas where they nest under and within logs and other debris, under stones, and in leaf litter," the U.S. Forest Service says. Environmental impacts According to Suiter, Asian needle ants wreak havoc in native environments. "They outcompete other ant species that are important to the ecology of that area," he says. Asian needle ants prey on other insects and are capable of displacing ant species that are critical for seed dispersal, according to the U.S. Forest Service. Researchers have documented large decreases in seed dispersal in forests where Asian needle ants are present. "Thus, this invasive species could have dramatic, long-term negative effects on forest understory," the service says. What should people do if they see Asian needle ants? Asian needle ants are about 0.2 inches in length, and dark brown or black with the end of the antennae and the legs being a lighter orange-brown, the U.S. Forest Service says. Other ant species can look similar, "so it takes an experienced eye to positively identify them," the service says. Suiter says that you can send a photograph or a specimen to a local University of Georgia Extension office, which can help with identification. The public can also contact a professional to come out and bait for the ants, he says. The U.S. Forest Service advises people to avoid the pest and to be especially vigilant in areas with logs and rotting or rocks were the ants can nest. "Unfortunately, as with many invasive species, it appears Asian needle ants are here to stay," the service says. Kristi Noem says "we are not going to let a repeat of 2020 happen" amid L.A. crackdown Magic in the dark: The fantastical worlds of Lightwire Theater Barbara becomes first hurricane of 2025 season to form in Pacific Ocean
Yahoo
5 hours ago
- Yahoo
Japan Facial Injectables Market Set to Reach Valuation of US$ 1,121.31 Million by 2033
Japan facial injectables market is set to thrives with growth in natural beauty trends, technological innovations, and urban demand. Despite regulatory and rural challenges, cultural shifts and economic factors fuel sustained growth potential. Chicago, June 09, 2025 (GLOBE NEWSWIRE) -- The Japan facial injectables market was valued at US$ 508.18 million in 2024 and is projected to reach US$ 1,121.31 million by 2033, growing at a CAGR of 9.52% during the forecast period 2025–2033. The Japan facial injectables market is experiencing a significant shift in consumer behavior with a growing preference for subtle, natural-looking enhancements over dramatic transformations. Younger demographics, particularly those in their 20s and 30s, are increasingly opting for preventative treatments like botulinum toxin to delay signs of aging. Social media platforms, such as Instagram and TikTok, play a pivotal role in shaping beauty ideals, with influencers promoting injectables as a routine part of self-care. Moreover, there is a noticeable rise in male consumers seeking facial injectables, driven by societal acceptance of male grooming and professional competitiveness. Request Sample Pages: This trend aligns with Japan's cultural emphasis on "kawaii" (cuteness) and polished aesthetics, pushing demand for products that enhance facial harmony. According to a 2024 survey by the Japan Aesthetic Medicine Association, over 60,000 men underwent injectable treatments last year, a sharp increase from previous years. Clinics in urban hubs like Tokyo and Osaka report a surge in demand for hyaluronic acid fillers for jawline contouring and under-eye rejuvenation. Additionally, the rise of hybrid work environments has reduced downtime concerns, encouraging more individuals to schedule quick procedures. As consumer awareness grows, brands are focusing on personalized treatment plans, ensuring safety and satisfaction in this evolving landscape of the Japan facial injectables market. Key Findings in Japan Facial Injectables Market Market Forecast (2033) US$1,121.31 million CAGR 9.52% By Product Type Botulinum Toxin/Botox (55.97%) By Age Group 35-50 Year (51.72%) By Gender Female (81.62%) By Clinic Type Dermatology Clinics (35.45%) By Application Wrinkle Reduction (39.97%) Top Drivers Japan's rapidly aging society seeking non-surgical facial rejuvenation solutions Growing acceptance of aesthetic procedures among younger Japanese professionals Advanced injection techniques developed specifically for Asian facial anatomy Top Trends Micro-dosing approaches gaining popularity for natural-looking results in Japan Preventative treatments starting earlier among Tokyo millennials and Gen-Z AI-powered facial analysis integration in Japanese aesthetic clinics nationwide Top Challenges Strict PMDA regulations limiting new product approvals and innovations High training requirements creating certified injector shortages across prefectures Price sensitivity among middle-income consumers limiting market expansion potential Technological Breakthroughs Redefining Aesthetic Treatments In the Japan facial injectables market, technological innovation is a key growth driver with new formulations and delivery methods enhancing treatment precision and outcomes. Advanced micro-droplet injection techniques are gaining popularity for their ability to deliver natural-looking results, particularly for delicate areas like under-eyes. Additionally, AI-powered consultation tools are transforming patient experiences, enabling simulations of post-treatment results. Major brands are also developing longer-lasting fillers with biocompatible materials tailored to Asian skin types. A report by the Japan Society of Aesthetic Surgery (JSAS) indicates that over 92,000 procedures utilized cutting-edge injection technologies last year, reflecting rapid market adoption. For instance, Galderma's latest hyaluronic acid filler, designed for thinner skin textures common in Japanese patients, saw over 30,000 applications in clinics nationwide. The rise of telemedicine platforms has further democratized access, with over 25,000 virtual consultations recorded for injectables in 2024. These advancements not only improve patient satisfaction but also attract tech-savvy millennials. Stakeholders can capitalize on this trend by investing in training for practitioners on novel technologies and partnering with tech firms for digital tools, positioning themselves as leaders in the innovation-driven Japan facial injectables market. Navigating Regulatory Hurdles in Aesthetic Innovations The Japan facial injectables market operates under a stringent regulatory environment, prioritizing patient safety while posing challenges for market entrants. The Pharmaceuticals and Medical Devices Agency (PMDA) mandates rigorous clinical trials for new products, often requiring Japan-specific data, which delays launches compared to regions like the EU. Advertising restrictions further complicate brand visibility, as clinics cannot make direct claims about treatment outcomes without substantiated evidence, impacting consumer outreach. Recent PMDA data from 2024 shows that approval times for new injectables have been reduced to an average of 10 months, down from 14 months in prior years, thanks to digital submission processes. However, only 1,200 certified dermatologists and plastic surgeons were licensed to perform advanced injectable treatments last year, limiting service availability. High-profile adverse reaction cases, such as a 2023 Tokyo incident involving off-label filler use affecting 50 patients, have tightened post-market surveillance. For stakeholders, navigating this landscape requires robust compliance strategies and investment in local clinical research. Building partnerships with certified practitioners and focusing on transparent communication can help overcome barriers in the Japan facial injectables market, ensuring trust and market penetration. Disparities in Urban and Rural Demand Patterns In the Japan facial injectables market, a significant urban-rural divide shapes demand dynamics as of 2024, driven by economic and accessibility factors. Urban hubs like Tokyo, Osaka, and Nagoya account for the majority of procedures, fueled by higher disposable incomes and exposure to global beauty trends via media. In contrast, rural regions lag due to fewer specialized clinics, lower awareness, and cultural hesitancy toward cosmetic enhancements, often viewing them as unnecessary or vain. According to a study by the Japan Cosmetic Industry Association (JCIA), Tokyo recorded over 78,000 injectable procedures last year, while rural prefectures like Shimane reported fewer than 2,000. Urban clinics also cater to convenience-driven clients, offering extended hours and premium services, with over 35,000 bookings for same-day treatments in Osaka. Rural consumers often travel to cities, facing additional costs, with travel-related expenses for treatments estimated at over US$500 per trip for 10,000 individuals in 2024. Stakeholders can address this gap by deploying mobile clinics or partnering with telemedicine platforms to offer virtual consultations. Targeted awareness campaigns highlighting safety and benefits could also boost rural adoption in the Japan facial injectables market, unlocking untapped potential. Competitive Dynamics Among Aesthetic Industry Players: Top 3 Players Control Nearly 60% Market Share The Japan facial injectables market is fiercely competitive as of 2024, with global and local players battling for dominance through innovation and brand trust. International leaders like Allergan (Botox) Galderma, and Medytox Inc leverage their extensive portfolios and global reputation, focusing on products suited for Asian facial structures. These 3 players collectively hold over 60% market share. On the other hand, domestic firms, such as Koken Co., are gaining ground with cost-effective fillers and culturally aligned marketing, appealing to price-sensitive consumers seeking trusted local brands. A 2024 report from the Japan Aesthetic Research Institute (JARI) notes that Allergan conducted over 55,000 Botox procedures last year, while Koken's fillers were used in 28,000 treatments, reflecting growing local traction. Strategic collaborations are key, with Merz partnering with 300 Tokyo clinics in 2024 for exclusive training, enhancing practitioner expertise. Local players counter with affordability, pricing treatments US$50-100 lower per session than global brands. Social media campaigns, involving over 200 influencers last year, have also become critical for brand visibility. For stakeholders, differentiating through niche offerings—like male-specific treatments or eco-friendly fillers—and building practitioner networks can secure a foothold in the dynamic Japan facial injectables market, balancing global standards with local relevance. Cultural Nuances Influencing Beauty Treatment Choices Cultural nuances profoundly influence the Japan facial injectables market as of 2024, shaping beauty perceptions and treatment choices. The Japanese ethos of 'mottainai' (avoiding waste) extends to maintaining a youthful appearance as a form of self-care and respect. Subtlety is prized, with consumers favoring injectables for minor enhancements like smoothing nasolabial folds over bold transformations, distinguishing Japan from markets like South Korea, where dramatic changes are often sought. A survey by the Japan Beauty Institute (JBI) found that 72,000 respondents preferred fillers for natural corrections, with over 40,000 treatments focusing on fine lines. J-pop and anime aesthetics drive younger demographics, with 25,000 procedures last year inspired by idol-like features. However, conservative attitudes among older generations persist, with only 15,000 clients aged 50+ opting for injectables due to stigma. Clinics in the Japan facial injectables market are reframing treatments as wellness solutions, hosting over 100 awareness seminars in 2024 to destigmatize aesthetics. Stakeholders can tap into this cultural landscape by emphasizing natural results and aligning with local beauty ideals. Tailored campaigns targeting younger and male demographics could further accelerate adoption in the market, blending tradition with modern aspirations. Economic Factors Steering Aesthetic Spending Trends Economic factors significantly impact the Japan facial injectables market as of 2024, with disposable income and cost pressures shaping consumer behavior. Japan's economy faces challenges like wage stagnation, limiting spending on non-essential services for middle- and lower-income groups. Urban professionals, however, view injectables as a career investment, prioritizing image in competitive job markets. Economic disparities thus create a segmented market where affluent areas drive the bulk of demand. A economic analysis by the Japan Finance Ministry highlights that import costs for foreign injectables rose in the facial injectables market due to a weaker yen, increasing treatment prices by US$20-30 per session in over 500 clinics. Despite this, demand in high-income Tokyo districts saw 58,000 procedures last year. Post-pandemic recovery has spurred discretionary spending, with over 30,000 young professionals using annual bonuses for aesthetics in 2024. Medical tourism, supported by government initiatives, also shows promise, with 5,000 international clients seeking treatments last year. Stakeholders can navigate economic constraints by offering tiered pricing or payment plans, ensuring accessibility. Leveraging tourism by marketing Japan as an aesthetic hub could further boost the market, aligning economic strategies with consumer realities. Need Custom Data? Let Us Know: Future Horizons for Aesthetic Treatment Innovations Looking forward, the Japan facial injectables market is poised for robust growth with emerging trends offering significant opportunities for stakeholders. Personalized treatments, aided by genetic profiling for customized fillers, are on the horizon, while male and senior demographics present untapped markets. Sustainability is also gaining traction, with biodegradable fillers attracting eco-conscious clients. The market is set to benefit from Japan's aging population, projected to drive demand for rejuvenation treatments. A forecast by the Japan Aesthetic Technology Forum predicts 45,000 users will adopt AR-based consultation tools by next year, enhancing treatment planning. Rural expansion via mobile clinics could reach 20,000 new clients annually, based on pilot programs in 2024. Global investment in Japanese aesthetic R&D is also rising, with over US$10 million allocated to local startups last year for innovative injectables. Challenges like regulatory delays and economic pressures remain, but strategic partnerships with tech firms and localized marketing can mitigate risks. For stakeholders, focusing on education, accessibility, and niche innovations—such as male-specific products—will be key to capitalizing on the evolving Japan facial injectables market, positioning Japan as a global leader in aesthetic advancements. Japan Facial Injectables Market Major Players: Galderma Allergan Aesthetics Medytox Inc. Hugel Inc. HA Derma VAIM Global Inc Other Prominent Players Key Segmentation: By Product Type Botulinum Toxin/Botox Derma Fillers Collagen Hyaluronic Acid (HA) Fat Injection Calcium Hydroxylapatite (CaHA) Poly-L-lactic Acid (PLLA) Others By Age Group 18-34 Years 35-50 Years 51+ Years By Gender Male Female By Clinic Type MedSpa Dermatology Clinics Hospitals Plastic Surgery Centers Others By Application Wrinkle Reduction Face Line Correction Lip Augmentation Face Lift Facial Contouring Acne Scar Treatment Lipoatrophy Treatment Others Need More Info? Ask Before You Buy: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
